|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Pneumology (Drs. Laaban, Pascal-Sebaoun, Orvoën-Frija, and Huchon), Nuclear Medicine (Dr. Bloch), and Nutrition (Dr. Oppert), Hotel-Dieu Hospital, Paris, France.
Correspondence to: Jean-Pierre Laaban, MD, FCCP, Department of Pneumology, Hotel-Dieu Hospital, 1, place du Parvis Notre-Dame, 75181 Paris Cedex 04, France; e-mail: j-pierre.laaban{at}htd.ap-hop-paris.fr
Study objectives: Conflicting results have been reported regarding the effects of obstructive sleep apnea syndrome (OSAS) on daytime left ventricular (LV) systolic function. This study aimed to assess the prevalence and causes of LV systolic dysfunction, using radionuclide angiography, in a large group of patients with OSAS.
Design and setting: A prospective study in the pneumology department of a university medical center.
Patients: One hundred sixty-nine consecutive patients with OSAS diagnosed by polysomnography, hospitalized for the administration of nasal continuous positive airway pressure. Patients with a known cardiac disease were excluded.
Measurements: LV ejection fraction (LVEF) was measured in all patients, using radionuclide ventriculography with multiple-gated equilibrium cardiac imaging. Myocardial scintigraphy with a dipyridamole stress test and echocardiography were performed in those patients with LV systolic dysfunction, defined by a LVEF < 50%, to detect silent heart disease, especially coronary artery disease.
Results: LV systolic dysfunction was observed in 7.7% (13 of 169 patients). In these 13 patients, the mean ± SD LVEF was 42 ± 6%, the lowest value of LVEF was 32%, and no silent cardiac disease was revealed. Age, body mass index, apnea-hypopnea index, parameters of nocturnal oxyhemoglobin desaturation, and prevalence of systemic hypertension did not significantly differ between patients with LVEF < 50% and those with LVEF > 50%. In seven patients with LV dysfunction, LVEF was measured following treatment of OSAS and reached normal values.
Conclusion: OSAS may be a direct cause of daytime LV systolic dysfunction that can resolve following reversal of nocturnal apneas.
Key Words: left ventricular ejection fraction left ventricular function obstructive sleep apnea syndrome positive airway pressure radionuclide ventriculography
This article has been cited by other articles:
![]() |
H. Nakashima, T. Katayama, C. Takagi, K. Amenomori, M. Ishizaki, Y. Honda, and S. Suzuki Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction Eur. Heart J., October 1, 2006; 27(19): 2317 - 2322. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Shivalkar, C. Van De Heyning, M. Kerremans, D. Rinkevich, J. Verbraecken, W. De Backer, and C. Vrints Obstructive Sleep Apnea Syndrome: More Insights on Structural and Functional Cardiac Alterations, and the Effects of Treatment With Continuous Positive Airway Pressure J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1433 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alonso-Fernandez, F. Garcia-Rio, M. A. Arias, O. Mediano, J. M. Pino, I. Martinez, and J. Villamor Obstructive sleep apnoea-hypoapnoea syndrome reversibly depresses cardiac response to exercise Eur. Heart J., January 2, 2006; 27(2): 207 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
L J Cormican and A Williams Sleep disordered breathing and its treatment in congestive heart failure Heart, October 1, 2005; 91(10): 1265 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Wong, T. O'Moore-Sullivan, R. Leano, N. Byrne, E. Beller, and T. H. Marwick Alterations of Left Ventricular Myocardial Characteristics Associated With Obesity Circulation, November 9, 2004; 110(19): 3081 - 3087. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Barnes, R. D. McEvoy, S. Banks, N. Tarquinio, C. G. Murray, N. Vowles, and R. J. Pierce Efficacy of Positive Airway Pressure and Oral Appliance in Mild to Moderate Obstructive Sleep Apnea Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 656 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Mansfield, N. C. Gollogly, D. M. Kaye, M. Richardson, P. Bergin, and M. T. Naughton Controlled Trial of Continuous Positive Airway Pressure in Obstructive Sleep Apnea and Heart Failure Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 361 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. M. Shamsuzzaman, B. J. Gersh, and V. K. Somers Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease JAMA, October 8, 2003; 290(14): 1906 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. o-D. L. Lattimore, D. S. Celermajer, and I. Wilcox Obstructive sleep apnea and cardiovascular disease J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1429 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bendjelid and J.-P. Laaban Left Ventricular Dysfunction and Sleep Apnea Syndrome: Cause or Consequence? Chest, May 1, 2003; 123(5): 1774 - 1775. [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |